A prospective, controlled, randomized trial of 3-, 7-, and 10-day rabeprazole-based triple therapy for H. pylori eradication in the USA

被引:0
|
作者
Vakil, N
Schwartz, HJ
Lanza, FL
Nardi, L
Hahne, W
Barth, J
机构
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
551
引用
收藏
页码:A65 / A65
页数:1
相关论文
共 50 条
  • [1] Seven-day rabeprazole-based triple therapy for H-pylori eradication is as effective as 10-day omeprazole-based triple therapy
    Vakil, N
    Schwarz, H
    Lanza, F
    Hahne, W
    Barth, J
    [J]. GUT, 2002, 51 : A95 - A96
  • [2] 10-day Sequential Versus Triple Therapy for H. pylori Eradication in Peptic Ulcer Patients: Prospective Randomized Trial
    Chung, Jun-Won
    Jung, Young Kul
    Kim, Yoon Jae
    Kim, Jung Ho
    Jeong, Jin-Yong
    Lee, Sun Mi
    Kwon, Kwang An
    Hahm, Ki Baik
    [J]. GASTROENTEROLOGY, 2012, 142 (05) : S488 - S488
  • [3] 7, 10 and 14-days rabeprazole-based standard triple therapies for H. pylori eradication: Are they still effective ? A randomized trial
    Karatapanis, S.
    Georgopoulos, S. D.
    Papastergiou, V.
    Skorda, L.
    Papantoniou, N.
    Lisgos, Ph.
    Kouvidou, C.
    Fragkou, P.
    Mentis, A.
    [J]. ACTA GASTRO-ENTEROLOGICA BELGICA, 2011, 74 (03) : 407 - 412
  • [4] Antimicrobial sensitivity in a large US multicenter trial of rabeprazole-based triple therapy for H. pylori eradication
    Vakil, N
    Jayanty, V
    Stanton, D
    Perdomo, C
    Hahne, W
    Barth, J
    [J]. GASTROENTEROLOGY, 2002, 122 (04) : A9 - A9
  • [5] Randomized controlled trial of rabeprazole, levofloxacin and rifabutin triple therapy versus rabeprazole-based quadruple therapy as a rescue treatment after failure of Helicobacter pylori (H. pylori) eradication with standard triple therapies
    Wong, WM
    Gu, Q
    Lam, SK
    Fung, FMY
    Lai, KC
    Xia, HHX
    Hu, WHC
    Wong, BCY
    [J]. GASTROENTEROLOGY, 2002, 122 (04) : A587 - A587
  • [6] Comparison of 10-day standard triple therapy and levofloxacin based therapy for Helicobacter pylori eradication: Randomized controlled trial
    Kang, Min Kyu
    Lee, Si Hyung
    Cho, Joon Hyun
    Kim, Sung Bum
    Kim, Kook Hyun
    Jang, Byung Ik
    Kim, Tae Nyeun
    Yang, Chang Heon
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 350 - 350
  • [7] Comparison of 10-day standard triple therapy and levofloxacin based therapy for Helicobacter pylori eradication: Randomized controlled trial
    Kang, M.
    Lee, S.
    Goo, E.
    Kim, K.
    Jang, B.
    Yang, C.
    [J]. HELICOBACTER, 2017, 22
  • [8] Economic analysis and outcomes of 10-day sequential therapy compared to 10-day triple therapy for Helicobacter pylori (H pylori) eradication
    Vakil, Nimish
    Zullo, Angelo
    Ricci, Chiara
    Vaira, Dino
    [J]. GASTROENTEROLOGY, 2008, 134 (04) : A619 - A619
  • [9] 4-day vs 7-day triple therapy with rabeprazole, clarithromycin and metronidazole for H. pylori eradication.
    Gambaro, C
    Bilardi, C
    Iiritano, E
    Dulbecco, P
    Biagini, R
    Mele, MR
    Borro, P
    Tessieri, L
    Zentilin, P
    Savarino, V
    [J]. GASTROENTEROLOGY, 2002, 122 (04) : A585 - A585
  • [10] Clarithromycin resistance and H pylori eradication rates in US racial groups with rabeprazole-based triple therapy
    Vakil, N
    Perdomo, C
    Barth, J
    [J]. GASTROENTEROLOGY, 2003, 124 (04) : A360 - A361